文献速递其他结缔组织病

系统性硬化症患者外周血基因表达谱及其对间质性肺疾病病程的预后意义

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2025-07-29

基于SENSCIS试验安慰剂臂数据,分析外周血细胞转录模块对系统性硬化症相关间质性肺疾病(SSc-ILD)患者第52周用力肺活量(FVC)%预计值下降的预后/预测意义。接受吗替麦考酚酯(MMF)治疗者(n=120)中,基线淋巴系及线粒体/蛋白合成模块较高与FVC%预计值病程较好相关,髓系及炎症模块较高与FVC%预计值下降较快相关;未接受MMF者(n=118)中仅髓系及炎症模块与FVC%预计值下降较快相关。

要点

  • 髓系谱系相关外周血细胞模块与SSc-ILD患者FVC%预计值下降较快相关,且不受MMF治疗影响。
  • 接受MMF治疗者中,基线淋巴系、蛋白合成及线粒体模块评分较高与SSc-ILD病程较好相关。
  • 未接受MMF者中,仅髓系谱系及炎症模块与FVC%预计值下降较快相关。

核心结论

  • 在SENSCIS试验的SSc-ILD患者中,涉及髓系谱系的外周血细胞模块与FVC下降较快相关,无论是否接受MMF治疗。
  • 在接受MMF治疗的患者中,基线淋巴系、蛋白合成及线粒体模块评分较高与SSc-ILD病程较好相关。
  • 血液基因表达谱可能作为SSc-ILD患者的预后/预测生物标志物。

研究设计与样本

  • 研究使用SENSCIS试验安慰剂臂数据,纳入SSc-ILD患者,首次非雷诺现象症状发生在7年内。
  • 允许使用MMF治疗,条件为稳定剂量使用≥6个月。
  • 基线采集外周血细胞RNA样本,进行全局RNA测序,并使用62个精选全血模块进行模块化分析。
  • 采用重复测量混合模型分析基线复合模块评分对第52周FVC%预计值下降的预后意义。

主要发现

  • 接受MMF治疗的患者(n=120)中,基线淋巴系及线粒体/蛋白合成模块较高与FVC%预计值病程较好相关。
  • 接受MMF治疗的患者(n=120)中,基线髓系谱系及炎症模块较高与FVC%预计值下降较快相关。
  • 未接受MMF治疗的患者(n=118)中,仅髓系谱系及炎症模块与FVC%预计值下降较快相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) with and without mycophenolate mofetil (MMF) treatment. METHODS: Patients had SSc-ILD with first non-Raynaud symptom within 7 years. MMF treatment was permitted if taken at a stable dose for ≥6 months. PBC RNA samples were taken at baseline. Global RNA sequencing was performed, followed by a modular analysis using 62 curated whole blood modules. The prognostic significance of baseline composite modular scores for decline in FVC% predicted at week 52 was analyzed using mixed models for repeated measures. RESULTS: Among patients taking MMF (n = 120), higher baseline lymphoid lineage and mitochondrial/protein synthesis modules were associated with a better course of FVC% predicted, whereas higher baseline myeloid lineage and inflammation modules were associated with a faster decline in FVC% predicted. Among patients not taking MMF (n = 118), only myeloid lineage and inflammation modules were associated with a faster decline in FVC% predicted. CONCLUSION: Among patients with SSc-ILD in the SENSCIS trial, PBC modules involved in myeloid lineage were associated with a faster decline in FVC regardless of MMF treatment. Higher baseline lymphoid, protein synthesis, and mitochondrial module scores were associated with a better course of SSc-ILD among patients receiving MMF treatment. Blood gene expression profiles might be useful prognostic/predictive biomarkers in patients with SSc-ILD.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Assassi S, Denton CP, Zwick M, et al. Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis. Arthritis Rheumatol. 2025. PMID: 40420438. doi:10.1002/art.43262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。